Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||
| Cash income from operating activities | 4.74%63.94M | 19.76%61.04M | 43.99%50.97M | 30.26%35.4M | -2.22%27.18M | 27.79M |
| Cash income from loans | 167.13%967K | 761.90%362K | 950.00%42K | 100.00%4K | -98.58%2K | --141K |
| Cash income from securities-related activities | -1.94%59.26M | 18.65%60.43M | 43.89%50.93M | 30.26%35.4M | -1.73%27.18M | --27.65M |
| Other cash income from operating activities | 1,368.38%3.72M | --253K | ---- | ---- | ---- | ---- |
| Cash paid | 90.48%-13.95M | -2,168.04%-146.54M | -26.69%-6.46M | -24.15%-5.1M | -4.72%-4.11M | -3.92M |
| Cash paid for bank and customer deposits | -21.84%-7.48M | -3.46%-6.14M | -24.32%-5.93M | -26.76%-4.77M | -8.54%-3.76M | ---3.47M |
| Other cash payments from operating activities | 95.39%-6.47M | -26,341.24%-140.4M | -60.91%-531K | 4.35%-330K | 24.34%-345K | ---456K |
| Operating cash flow | 158.47%49.99M | -292.07%-85.49M | 46.90%44.51M | 31.35%30.3M | -3.36%23.07M | --23.87M |
| Investing cash flow | ||||||
| Cash flow from continuing investing activities | 0 | 98.85%-2.2M | -23,815.13%-191.32M | 98.92%-800K | -74.07M | |
| Net investment purchase and sale | ---- | ---- | 98.83%-2.2M | -23,356.25%-187.65M | 98.91%-800K | ---73.5M |
| Net proceeds payment for loan | ---- | ---- | ---- | ---3.67M | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---3.67M | ---- | ---570K |
| Cash from discontinued investing activities | ||||||
| Investing cash flow | --0 | ---- | 98.85%-2.2M | -23,815.13%-191.32M | 98.92%-800K | ---74.07M |
| Financing cash flow | ||||||
| Cash flow from continuing financing activities | -159.78%-51.49M | 306.11%86.14M | -125.98%-41.79M | 835.54%160.86M | -195.94%-21.87M | 22.8M |
| Net issuance payments of debt | ---- | ---- | ---- | --188.88M | ---- | ---- |
| Net commonstock issuance | ---- | --136.94M | ---- | ---- | ---- | --45M |
| Cash dividends paid | -1.35%-51.49M | -21.57%-50.81M | -49.10%-41.79M | -28.17%-28.03M | 1.51%-21.87M | ---22.21M |
| Cash from discontinued financing activities | ||||||
| Financing cash flow | -159.78%-51.49M | 306.11%86.14M | -125.98%-41.79M | 835.54%160.86M | -195.94%-21.87M | --22.8M |
| Net cash flow | ||||||
| Beginning cash position | 34.98%2.48M | 39.45%1.84M | -11.13%1.32M | 36.93%1.48M | -96.20%1.08M | --28.49M |
| Current changes in cash | -333.59%-1.5M | 23.65%643K | 415.15%520K | -141.25%-165K | 101.46%400K | ---27.41M |
| End cash position | -60.54%979K | 34.98%2.48M | 39.45%1.84M | -11.13%1.32M | 36.93%1.48M | --1.08M |
| Free cash from | 158.47%49.99M | -292.07%-85.49M | 46.90%44.51M | 31.35%30.3M | -3.36%23.07M | --23.87M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |